Literature DB >> 19628387

Synthesis and evaluation of 6-methyl-3-phenylcoumarins as potent and selective MAO-B inhibitors.

Maria Joao Matos1, Dolores Viña, Carmen Picciau, Francisco Orallo, Lourdes Santana, Eugenio Uriarte.   

Abstract

A series of 6-methyl-3-phenylcoumarins 3-6 were synthesized and evaluated as monoamine oxidase A and B (MAO-A and MAO-B) inhibitors. A comparative study between the three possible mono methoxy 3-phenyl derivatives and the p-hydroxy analogue is reported. The synthesis of these new resveratrol-coumarin hybrids was carried out by a Perkin reaction between the 5-methylsalicylaldehyde and the corresponding phenylacetic acids. The p-methoxy substituted compound 3 was hydrolyzed to 6 by a traditional reaction with hydriodic acid. The prepared compounds show high selectivity to the MAO-B isoenzyme, some of them with IC(50) values in the low nanomolar range. Compound 4, with the methoxy group in meta position, is the most active of this series, with an IC(50) against MAO-B of 0.80 nM, and is several times more potent and MAO-B selective than the R-(-)-deprenyl (reference compound).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19628387     DOI: 10.1016/j.bmcl.2009.07.039

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  9 in total

Review 1.  Roles of selected non-P450 human oxidoreductase enzymes in protective and toxic effects of chemicals: review and compilation of reactions.

Authors:  Slobodan P Rendić; Rachel D Crouch; F Peter Guengerich
Journal:  Arch Toxicol       Date:  2022-06-01       Impact factor: 6.168

2.  Design, Synthesis, and Antifungal Activity of 4-Amino Coumarin Based Derivatives.

Authors:  Lu Xu; Jinmeng Yu; Lu Jin; Le Pan
Journal:  Molecules       Date:  2022-04-24       Impact factor: 4.927

Review 3.  Computer-aided Drug Design Applied to Parkinson Targets.

Authors:  Hamilton M Ishiki; Jose Maria Barbosa Filho; Marcelo S da Silva; Marcus T Scotti; Luciana Scotti
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

4.  Novel C7-Substituted Coumarins as Selective Monoamine Oxidase Inhibitors: Discovery, Synthesis and Theoretical Simulation.

Authors:  Dong Wang; Ren-Yuan Hong; Mengyao Guo; Yi Liu; Nianhang Chen; Xun Li; De-Xin Kong
Journal:  Molecules       Date:  2019-11-05       Impact factor: 4.411

Review 5.  Molecular docking studies of coumarin hybrids as potential acetylcholinesterase, butyrylcholinesterase, monoamine oxidase A/B and β-amyloid inhibitors for Alzheimer's disease.

Authors:  Samina Khan Yusufzai; Mohammad Shaheen Khan; Othman Sulaiman; Hasnah Osman; Dalily Nabilah Lamjin
Journal:  Chem Cent J       Date:  2018-12-04       Impact factor: 4.215

6.  Structure-Activity Relationship Analysis of 3-Phenylcoumarin-Based Monoamine Oxidase B Inhibitors.

Authors:  Sanna Rauhamäki; Pekka A Postila; Sanna Niinivehmas; Sami Kortet; Emmi Schildt; Mira Pasanen; Elangovan Manivannan; Mira Ahinko; Pasi Koskimies; Niina Nyberg; Pasi Huuskonen; Elina Multamäki; Markku Pasanen; Risto O Juvonen; Hannu Raunio; Juhani Huuskonen; Olli T Pentikäinen
Journal:  Front Chem       Date:  2018-03-02       Impact factor: 5.221

7.  Coumarin analogue 3-methyl-7H-furo[3,2-g] chromen-7-one as a possible antiparkinsonian agent

Authors:  María Del Pilar Olaya; Nadezdha Esperanza Vergel; José Luis López; María Dolores Viña; Mario Francisco Guerrero
Journal:  Biomedica       Date:  2019-09-01       Impact factor: 0.935

8.  3-Phenylcoumarins as inhibitors of HIV-1 replication.

Authors:  Dionisio Olmedo; Rocío Sancho; Luis M Bedoya; José L López-Pérez; Esther Del Olmo; Eduardo Muñoz; José Alcamí; Mahabir P Gupta; Arturo San Feliciano
Journal:  Molecules       Date:  2012-08-02       Impact factor: 4.411

9.  Synthesis and structure-activity relationships of novel amino/nitro substituted 3-arylcoumarins as antibacterial agents.

Authors:  Maria J Matos; Saleta Vazquez-Rodriguez; Lourdes Santana; Eugenio Uriarte; Cristina Fuentes-Edfuf; Ysabel Santos; Angeles Muñoz-Crego
Journal:  Molecules       Date:  2013-01-24       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.